Crossmark

Ruxolitinib therapy and telomere length in myelofibrosis

Crossref DOI link: https://doi.org/10.1038/bcj.2016.91

Published Online: 2016-10-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Caocci, G https://orcid.org/0000-0002-6585-5187
Greco, M

Delogu, G

Secchi, C

Perra, A

Ghiani, S

Orru, F

Vacca, A

Galimi, F

La Nasa, G
License Information

Text and Data Mining valid from 2016-10-07

Version of Record valid from 2016-10-07
More Information

Article History

First Online: 7 October 2016

Competing interests

: The authors declare no conflict of interest.